REINITIALISE - pREservIng fuNdamental rIghTs in the use of digitAl technoLogIes for e-health ServicEs
From 01-09-2020 to 31-08-2023
Description
REINITIALISE aims to strengthen scientific excellence and innovation capacity at UMCS (PL) in the field of preservation of fundamental rights in the design and use of digital technologies and digital communication for e-health services, with a specific focus on a) health-oriented technologies for active ageing, and b) prevention care in the sectors of nutrition and dietetics. Within this overall objective, REINITIALISE also aims to increase the capacity to attract and successfully manage EU funds at UMCS, and to involve, train and mentor Early-Stage Researchers (ESRs).
The twinning exercise carried out by REINITIALISE defines and implements a scientific strategy and a process of knowledge transfer which leverages on excellence of KUL (BE), UNIMC (IT), and EUC (IT), as well as on complementarities and synergies among Smart Specialization Strategies of the 3 regions involved.
To achieve these goals, REINITIALISE puts together a comprehensive plan of collaborative activities, characterized by:
- attention to reinforce the strategic thinking capacities of UMCS;
- a highly interdisciplinary approach, supported by the integration between social sciences and humanities and technology;
- a constant and active involvement of different stakeholders and the business community;
- an ad hoc training and mentoring for ESRs;
- an ad hoc training on EU project design and management of EU funds.
The plan of collaborative activities includes: staff exchanges for senior researchers and ESRs, academic symposiums, job shadowing and cross functional mentoring, showcase events, lunch & learn events, summer and winter schools, Venture Lab.
With regard to the Work Programme, REINITIALISE contributes to the reduction of internal disparities in the EU in terms of R&I performances, by focusing on UMCS and leading it towards a pathway of excellence. Also the Lubelskie region, where UMCS is based, will benefit from the project especially in terms of opportunities for socio-economic growth.
Team
- Bart Vanrumste, Promoter
Financing
Funding: EU Funding - European Funding
Program/Grant Type: EU Other - Other
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.